Canada markets close in 1 hour 2 minutes

Knight Therapeutics Inc (04K.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
3.9600-0.0800 (-1.98%)
As of 08:38PM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
332,206
328,199
293,563
243,478
199,519
-
Cost of Revenue
178,617
175,547
155,502
128,066
117,829
-
Gross Profit
153,589
152,652
138,061
115,412
81,690
-
Operating Expenses
Research Development
18,342
17,549
14,755
12,692
11,725
-
Selling General and Administrative
87,109
83,693
88,624
74,376
74,430
-
Total Operating Expenses
150,192
146,282
155,121
128,244
111,690
-
Operating Income or Loss
3,397
6,370
-17,060
-12,832
-30,000
-
Interest Expense
12,274
12,488
6,600
3,618
3,398
-
Total Other Income/Expenses Net
-27,173
-28,445
-30,932
15,758
51,161
-
Income Before Tax
-24,186
-21,988
-43,960
6,690
32,085
-
Income Tax Expense
-6,742
-5,153
-14,068
-8,985
325
-
Income from Continuing Operations
-17,444
-16,835
-29,892
15,675
31,760
-
Net Income
-17,444
-16,835
-29,892
15,675
42,067
-
Net Income available to common shareholders
-17,444
-16,835
-29,892
15,675
42,067
-
Basic EPS
-0.06
-
-0.26
0.13
0.32
0.10
Diluted EPS
-0.06
-
-0.26
0.13
0.32
0.10
Basic Average Shares
109,759
-
114,890
124,480
131,783
139,759
Diluted Average Shares
109,931
-
114,890
124,522
131,985
140,139